Kernberg, 2006), and improvement in personality organization (Doering, Hörz, Rentrop, Fischer- Kern, Schuster, Benecke, Buchheim, Martius, & Buchheim, 2010). We have isolated predictors of change and rates of change in the treatment of BPD patients (Lenzenweger, Clarkin, Levy, Yeomans, & Kernberg, 2012). Our current work builds on these previous findings. We are in the process of using pre-treatment genetic markers combined with neurocognitive functioning (fMRI) to predict response to TFP over a treatment episode of 18 months. A major goal of the extended treatment is not only symptom reduction, but also significant improvement in work functioning and satisfaction in interpersonal relations. G$#.1/.\! John F. Clarkin, Ph.D., Clinical Professor of Psychology in Psychiatry, Weill Cornell Medical College, New York Presbyterian Hospital Westchester, 21 Bloomingdale Road, White Plains, NY 10605.
CVT
.01230/1.40/5&&'67894/0/571.8/5&&/6648./1.40&
Made with FlippingBook Ebook Creator